Key Highlights

  • CTS Corporation's $0.04 quarterly Dividend trades ex-date September 25, 2026, payable October 23, unchanged from prior quarters.
  • Second-quarter net sales were $144.780 million, up 7% year over year, with Net Income of $19.164 million, or $0.66 diluted EPS.
  • Adjusted gross Margin reached a record 41.5%, up 270 basis points, while diversified end-market sales grew 15% and now represent 59% of total sales.
  • The company raised full-year 2026 guidance to sales of $565-$585 million and adjusted diluted EPS of $2.55-$2.70.

Overview

CTS Corporation's (NYSE:CTS) $0.04 quarterly dividend yields approximately 0.27% and has remained unchanged through a quarter of record adjusted profitability, a payout level that represents a small fraction of the company's $0.66 GAAP diluted EPS. The dividend is a fixed per-share amount without a stated payout-ratio target, evaluated alongside CTS's broader Capital allocation that includes reinvestment in diversified end markets under its Evolution 2030 strategy.

Dividend Program and Shareholder Returns

CTS maintains a regular quarterly common dividend of $0.04 per share, declared August 14, 2026, payable October 23 to shareholders of record September 25. The rate equals $0.16 annualized and has remained unchanged through the first three quarters of 2026. The dividend is discretionary and separate from share repurchases and other capital uses; CTS is not subject to a statutory distribution requirement.

About the Company

CTS designs and manufactures sensors, connectivity components and actuators used in medical, industrial, aerospace and defense, and transportation applications. Operating across North America, Asia and Europe, the company's Evolution 2030 strategy emphasizes diversification, technology and margin expansion, reducing dependence on the transportation end market.

Financial Performance Behind the Payout

CTS reported second-quarter net sales of $144.780 million, up 7% year over year, with sales to diversified end markets increasing 15% and now representing 59% of total sales, while transportation sales declined 2%. Net income was $19.164 million, or $0.66 diluted EPS, versus $18.527 million, or $0.62, a year earlier. Adjusted gross margin reached a record 41.5%, up 270 basis points, and adjusted diluted EPS was $0.74. Operating Cash Flow was $33.4 million, up from $28.4 million. The book-to-bill ratio was 1.17x, and new awards during the quarter totaled approximately $163 million, including a roughly $100 million sensor contract.

Diversification Driving Record Margins Under New Leadership

CTS's shift toward medical, industrial, and aerospace and defense markets, now 59% of sales, is the primary driver behind the record 41.5% adjusted gross margin, a structural change the company attributes to favorable end-market mix alongside operational execution and a modest foreign-exchange benefit. Management has said approximately 7 cents of the quarter's adjusted EPS reflected unusual items, a specifically identified Factor relevant to assessing how much of the Earnings strength is likely to recur. The raised full-year guidance to $565-$585 million of sales and $2.55-$2.70 of adjusted diluted EPS, up from a prior range, incorporates continued diversified-market growth alongside flat-to-modestly-lower global light-vehicle production assumptions for the transportation segment.

Outlook

CTS's $0.04 dividend has remained unchanged through the first three quarters of 2026 amid record adjusted profitability. Diversified end-market growth relative to the 15% pace reported this quarter, transportation-segment trends amid Tariff and geopolitical uncertainty, and execution against the raised full-year guidance range are the relevant considerations.